Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib
Trial:
A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Leuven Cancer Institute, Catholic University Leuven

Herestraat 49     B-3000
Leuven ,
Belgium

 

Principal Investigator:
 Patrick Schoffski
Contact:
 Patrick Schoffski +32-16-346900; patrick.schoffski@uzleuven.be
Activation Status of this Site:
 Active
Notes about this Site:
Leuven Cancer Institute, Catholic University Leuven Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.